I want to tell you something a little uncomfortable about the pet supplement industry, and I want to tell it the way I'd tell a friend across a bar, not the way I'd write it for a regulator.

The phrase "veterinarian formulated" is not a standard. It is not a certification. There is no board that audits it, no lab that verifies it, no dosing floor it has to clear. It is a marketing claim, and its legal ceiling is functionally this... a vet, somewhere, at some point, looked at the ingredient list. That is the entire test.

Which is why we don't lean on the phrase, and why I want to spend the next couple thousand words on what should actually be underneath it.

The 100-Word Answer, Before We Go Any Deeper

A therapeutic canine soft chew is defined by four engineering variables, not by a phrase on the front of the bag: the manufacturing method (cold-form vs. high-heat extrusion), the binder and filler load (functional carriers vs. cheap volume), the palatant (real protein signal vs. synthetic flavor cocktail), and the delivery matrix (whether the actives actually reach the cell). Every one of these decisions is made months before the ingredient panel is written. As of 2026, Arterra defines a real longevity chew as one where all four variables were engineered for bioavailability first, and shelf appeal never.

The Standard Industry Myth We Have to Bury First

The myth is that the ingredient panel is the product.

Owners have been trained to read the label the way you'd read a menu. Turmeric, check. Glucosamine, check. Probiotics, check. Twenty-eight ingredients across five columns. If you've been in the aisle at PetSmart on a Sunday afternoon watching a young couple deliberate between three bottles, you've watched this exact ritual. They read the panel. They compare the panel. They pick the one with the longer panel.

The panel is not the product.

The product is the panel plus the manufacturing decisions plus the delivery architecture plus whether the ingredient survived the process it was extruded through at 180 degrees Fahrenheit. A soft chew is a delivery vehicle. Everything about how that vehicle is built decides whether the payload ever gets where it's going. Read only the panel, and you're reading the sticker on the outside of a truck. You have no idea what's in the trailer, or if the trailer is even attached.

This is where "veterinarian formulated" gets weaponized. It gets slapped on the front of the bag to soothe the reading. It tells you a professional touched this. It does not tell you what the professional was paid to say, or whether the co-manufacturer who actually makes the chew ran it through the same industrial process they run every other brand's chew through the next day of the week.

What "vet-formulated" usually means in practice

In practice, most vet-formulated claims in the mass market break down into one of three tiers.

1. A consulting veterinarian reviewed the ingredient list. They signed off on the identities and the general dose ranges. They likely did not tour the manufacturing facility. They almost certainly did not design the delivery matrix.
2. A staff veterinarian is on payroll. They lend their name to the marketing, sometimes to their own detriment. They may or may not have influence over sourcing, and they rarely have influence over the co-manufacturer's process settings.
3. A veterinarian founded the brand. This is the version that means the most, and it is also the rarest. Even then, the question is whether the founder is still writing the formulation brief, or whether the brand has been acquired and the founder's name is now a legacy asset on the front of a bag being made by a private equity roll-up.

None of these tiers is illegal. None is even necessarily bad. They just aren't a standard. They are marketing decisions that vary from company to company and, in many cases, from year to year within the same company.

The only real question worth asking is what actually happens to the chew between the ingredient sourcing and the moment it lands in your dog's mouth. That is the engineering conversation. Let's have it.

Manufacturing Method: The Decision Almost No Label Explains

Soft chews, at industrial scale, are almost always made by hot extrusion. A wet slurry of binders, actives, palatants, and flavor is fed into a heated barrel. A screw drives the mass through a die at temperatures that typically run between 160 and 200 degrees Fahrenheit. The extrudate is cut into portions, cooled, and packed. The whole cycle is fast, cheap, and clean-looking, which is exactly why the mass market runs on it.

Here is what heat does to your actives.

Heat-sensitive nutrients degrade

Probiotic cultures are the obvious casualty. Live bacterial strains rated for a specific CFU count at bottling can lose one to two log-orders of viability through a hot extrusion cycle. The label still lists the CFU. The organism just isn't there in the count you paid for.

Vitamin C degrades. Certain B-vitamins degrade. Naturally occurring enzymes denature. Some polyphenolic compounds lose their oxidation-quenching structure. The chemistry is not controversial. It is standard food-science pedagogy, taught in every undergraduate food-processing course. Reviews of thermal degradation kinetics in nutraceutical processing indexed through the National Library of Medicine lay out temperature-time relationships for individual actives in detail. The pet supplement industry knows this. The pet supplement label rarely mentions it.

Lipid actives oxidize

Fish oil, algal DHA, and other polyunsaturated fatty acids are particularly vulnerable. Heat plus oxygen plus time equals lipid peroxidation. What you fed the dog is chemically not what you thought you fed the dog. In some cases, the oxidized byproducts are actively pro-inflammatory... the opposite of the intended function.

The alternative

Cold-form manufacturing compresses the same slurry at room temperature, or at temperatures modestly above room temperature that never approach the degradation thresholds of the sensitive actives. The chew comes out slightly denser, sometimes slightly less shelf-stable, and considerably more expensive per unit to produce. But the actives arrive at the panel-listed dose because nothing along the way degraded them out of the count.

We do not make marketing claims about the specific process settings we use, because that is competitive information. What I will tell you plainly is this: if you cannot preserve the ingredient's biological function through your manufacturing method, you should not put the ingredient in the chew. That is the discipline. Either the process protects the payload, or you change the process, or you leave the ingredient out. What you do not do is list it and hope no one measures.

The Binder Audit: What's Really Holding the Chew Together

Turn the bag over and read past the actives. The bottom half of the ingredient panel is where the truth lives.

Most mass-market soft chews list, somewhere in the top five ingredients, some combination of glycerin, palm oil or hydrogenated palm oil, corn starch, tapioca starch, molasses, and synthetic gums. These are the binders and the fillers. They are what gives the chew its structure, its cost target, and its mouthfeel.

Individually, none of them is poison. Collectively, they are often 60 to 75 percent of the chew by mass. Which means when you feed a soft chew that costs the company nine cents to produce and retails for a dollar, you are largely feeding your dog glycerin and starch with an active dusting on top.

Glycerin, specifically

Glycerin is a humectant. It holds water in the chew so the chew doesn't dry out. It also happens to be sweet, which the dog reads as reward, which is convenient for palatability. It is a solvent, not a nutrient. In small quantities it is well tolerated. As the second or third ingredient by mass, it becomes the diet, not the vehicle for the diet. That is a meaningful distinction that the front of the bag never draws.

Starch

We wrote the full argument on starch in the dental context in The Starch Trap, and the argument transfers directly to longevity chews. Starch feeds oral biofilm on the way in and contributes glycemic load on the way through. Neither serves the dog. Both serve the manufacturer's margin.

The Arterra call

Our formulation brief has one line about binders that I remember from the first draft, and I want you to see it in the plain form we wrote it in.

No binder is neutral. Every binder is either doing biological work or it is displacing something that could.

That constraint kills most of the industry-default carrier options on sight. What survives is a much shorter list of functional carriers... natural humectants that do double duty as nutrients, functional fibers with prebiotic activity, minimum viable binder mass so the chew holds together and no more. The chew is slightly less pillowy for it. The chew is also mostly the thing you paid for.

The Palatant: The Filet Mignon Standard, Explained Honestly

A dog does not read the ingredient panel. A dog reads the smell.

Palatants exist because manufacturers need to guarantee the dog will eat the chew. If the dog spits it out, none of the engineering downstream matters. So the palatant question is real. The palatant answer is where the industry gets lazy.

Standard commodity palatants in the pet supplement category are chemical cocktails engineered to smell and taste like protein without actually being protein. "Chicken flavor," "bacon-style," "smoke-flavor," "poultry-type." These are almost always some combination of hydrolyzed vegetable protein plus flavor compounds plus a fat carrier. The dog's amygdala registers something that smells vaguely like meat and green-lights consumption. The dog's amino-acid receptors, if they were paying attention, would notice they never actually saw a peptide chain of real protein cross the tongue.

We use Filet Mignon natural flavor. Not because it plays well in marketing (it does), but because a real protein signal produces a different behavioral and physiological response than a synthetic mimic. The dog reads it as food. The digestive system primes for the arrival of actual amino acids. The chew is consumed with the enthusiasm of a treat, not the compliance of a pill. We wrote the fuller argument in The Truth About Synthetic Flavors.

The math on this is not close. Real protein palatants cost roughly an order of magnitude more per kilogram than synthetic. That is why the mass market doesn't use them. The math from the dog's side works differently.

The Delivery Matrix: The Silent Variable That Decides Everything

The last engineering layer is the one the industry talks about the least, because it is the one that requires actual formulation science.

The delivery matrix is the chemistry that surrounds each active and decides whether it reaches the bloodstream in a form the cell can use.

You can put curcumin in a chew and technically call your formula "anti-inflammatory." Raw curcumin absorbs at somewhere between two and five percent of the ingested dose. The rest transits the gut and exits unchanged. If you want curcumin to actually reach systemic circulation, you formulate it with a lipid carrier or in a phytosome complex. That is not a marketing choice. That is chemistry.

You can put vitamin E in a chew. Synthetic dl-alpha-tocopherol is bioavailable at roughly half the potency of natural d-alpha-tocopherol on a milligram-for-milligram basis. Same word on the label. Very different molecules at the receptor.

You can put magnesium in a chew. Magnesium oxide costs a dollar a kilo and absorbs at four percent. Magnesium glycinate costs twenty times as much and absorbs at forty percent. Ten times the delivered dose from the same nominal amount. The label rarely tells you which form is in the bag.

Multiply this across an ingredient panel of twenty-plus actives and you understand why two supplements with identical-looking labels can produce entirely different biological outcomes. We covered the deeper physiology in Bioavailability 101. The engineering point here is that bioavailability is designed in at the formulation stage or it is not designed in at all. You cannot add it after the fact.

Every active in the Arterra Longevity Multivitamin is specified in the form the research supports for canine absorption. Chelated minerals, not oxide salts. Natural tocopherols, not synthetic. Lipid-matrix formulation for fat-soluble actives so the gut has something to escort them across the epithelium with. This is expensive. It is also the only way the milligram on the label becomes the milligram in the cell.

Dose Uniformity: The Problem Nobody Wants to Discuss

One last engineering variable worth naming, because it separates a real manufacturing operation from a hopeful one.

Extruded soft chews have historically had a dose uniformity problem. The active-to-carrier ratio is small. The mixing has to be extraordinarily good to keep the ratio consistent from chew to chew. In practice, many mass-market soft chews show meaningful variation between individual units in the same bag. The average across the bag matches the label. The individual chew you handed your dog on Tuesday morning may or may not.

Cold-form processes, run with adequate mixing time and QC verification, produce more consistent unit doses. This matters less for a preventive vitamin taken over years. It matters a lot for a therapeutic active where the biological effect depends on hitting a threshold. If your dog is on a longevity protocol because you actually want the protocol to work, dose uniformity is not optional. It is the price of entry.

The Arterra Design Brief, In Plain Language

When we sat down to design the Longevity Multivitamin, the brief was three sentences.

1. Every active is dosed at the level the peer-reviewed literature supports as therapeutically active for the target canine weight range. If the therapeutic dose is impossible to fit into a chew of reasonable size, the active does not go in the chew.
2. Every ingredient is in the form with the highest published bioavailability. If the bioavailable form is cost-prohibitive, we absorb the cost. We do not swap in the cheaper form and hope.
3. Every carrier and palatant is chosen so that it either does biological work or displaces the minimum possible mass. Nothing on the ingredient panel is decoration.

That's the brief. Everything downstream of that... the manufacturing method, the QC protocol, the dosing schedule, the packaging that protects the actives from oxygen and light... follows from those three sentences.

It is not a complicated brief. It is a demanding one. Most of the industry cannot meet it at the price point they need to hit on the shelf, which is why most of the industry does not try. We built Arterra as a direct-to-consumer brand specifically so we could refuse the mass-market cost structure and run the brief the way it was written.

FAQ

Is "human-grade" the same as clinical-grade for a dog supplement?

No. "Human-grade" is a food-safety claim about the input ingredients being handled to human food standards. It tells you nothing about the dose, the form, the delivery matrix, or the manufacturing process. A human-grade chew can still be sub-therapeutic and industrially extruded. The two conversations do not overlap as much as the marketing implies.

How do I evaluate a soft chew if I can't visit the factory?

Read the label with the four variables in mind. Where does glycerin appear? (Higher than fourth position by mass, be suspicious.) What form is each mineral in? ("Oxide" is a cheap-form flag.) What is the palatant? ("Natural chicken flavor" is not the same as "chicken.") Is any thermal-sensitive ingredient present with a stability guarantee? (If probiotics are listed with no CFU guarantee through shelf life, treat as marketing.) The label rewards a careful reader more than most owners realize.

Are all extruded chews bad?

No. Extrusion is a fine process for chews whose actives are heat-stable and whose bioavailability doesn't depend on delicate delivery chemistry. The problem is when a brand extrudes a formula that includes probiotics, polyunsaturated fats, or heat-sensitive vitamins and prints the pre-processing dose on the label. That is a labeling problem more than a process problem. Match the method to the payload.

Why doesn't Arterra just call itself "veterinarian formulated" and be done with it?

Because the phrase is no longer a promise. It is a marketing convention, and using it without qualification would put us in the same visual bucket as the products we compete against. We prefer to describe what we actually did. The people we're built for read carefully enough to notice the difference.

What This Amounts To

The people who care about their dog's longevity are the same people who read the back of their own supplement bottles, who ask their doctor which form of magnesium to use, who track their macronutrients, who quietly maintain a spreadsheet of their own bloodwork over the years. They know what a therapeutic dose looks like. They know the difference between a claim and a mechanism. They know that "formulated by an expert" is not the same as "engineered for outcome."

They are the reason we do this the hard way.

Building a longevity chew that meets the brief costs more, ships slower, and makes for a less crowded ingredient panel. It also gets absorbed at doses that produce measurable biological change, over the years that decide whether your dog spends thirteen as a peer or as a patient.

You do not get to do this twice with the same dog.

Health is an investment in time.

Optimize Your Dog's Longevity →

Related reading: The Canine Longevity Protocol, Bioavailability 101, The Window-Dressing Lie.

Sources: National Library of Medicine, NCBI literature on thermal degradation of nutraceuticals and nutrient bioavailability (ncbi.nlm.nih.gov); American Veterinary Medical Association guidance on pet supplement quality (avma.org).

Previous Article

July 21, 2026

The Science of nHA: How Nano-Hydroxyapatite Rebuilds Your Dog's Enamel

Next Article

July 28, 2026

The Role of Banana Fiber in Canine Oral-Gut Signaling